This videao provides an overview of the I-MASK protocl
Results from a Phase 3 clinical trial involving over 43,000 participants of an mRNA-based vaccine candidate called BNT162b2 show that it is 90% effective in preventing COVID-19 infections. The vaccine is a joint venture between Pfizer and BioNTech. Patients received…
Nonpareil, intellectually courageous infectious diseases (ID) epidemiologists Dr. Sunetra Gupta (Oxford University), Dr. Jay Bhattacharya (Stanford University), and Dr. Martin Kulldorff (Harvard University) describe an evidence-based, unhysterical approach to managing the covid-19 pandemic: Allowing the vast preponderance of the world’s…
We’re all no stranger these days to attacks on the immune system. We are in the middle of a #COVID19 pandemic globally where we are all encouraged to prevent illness or afflictions. Did you know that you have more power…
Webinar hosted on September 10, 2020 by the National Institute for Health Care Management (NIHCM) Foundation Detailed information available on our website: Remarks by: – Jack Shonkoff, MD, Harvard University, Center on the Developing Child – Jane Stevens, ACEs Connection…
